As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Giavedoni, Luis D.
Funded by
Beth Israel Deaconess Med Ctr
TxBiomed is processing Luminex assays for a service fee.
EO2 Concepts (EO2), is an advanced wound care technology company.
Principal Investigator(s)
Mark Couture, DPM
Funded by
EO2
Collaborating Institutions
Central Texas Veteran’s Healthcare Administration, Temple, TX
The purpose of this project is to describe healing outcomes in the VA for the treatment of chronic ulcers using Continuous Diffusion of Oxygen therapy (CDO). CDO is a form of moist wound therapy whereby pure oxygen is added within the moist wound therapy dressing using a portable system. The system used for this study will be the TransCu O2 System, which consists of a handheld oxygen generator, a cannula for delivering the oxygen to the wound and moist wound therapy dressings. In other words, CDO is moist wound therapy with added pure oxygen supplied continuously.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
SAIC-Frederick
The Subcontractor shall furnish the necessary ABSL-4 non-human primate facility equipment and caging, management oversight and personnel for the performance of laboratory animal support services, and select BSL4 challenge material (filoviruses e.g. Ebola, Marburg) to test various novel compounds against filovirus infection.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Carrion, Ricardo
Funded by
Fisher BioServices
TxBiomed will furnish the necessary services, qualified personnel, material, equipment and facilities to perform vaccine testing using the Sudan GP virus.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Hayhurst, Andrew
Funded by
NIH-PMS
Mining recombinant antibody libraries for binders that function well together in an immunoassay is a critical component of developing diagnostics for infectious disease agents and assays for host biomarkers to study disease processes. While identifying antibodies that bind the antigen of interest is reasonably straightforward, combining them in a sandwich assay demands protein purification and in vitro modification, processes that rapidly escalate costs and time when pairing hundreds of potential clones.
Cancer Insight is a Texas-based boutique contract research organization (CRO) dedicated to discovering, developing and testing emerging biotechnologies focused on cancer immunotherapy. Founded by industry pioneer Dr.
Principal Investigator(s)
George Peoples
Funded by
Industry Sponsored
The purposes of the study are as follows: 1) to test the development of a potential anticancer study called E39 peptide vaccine and J65 peptide vaccine; 2) to determine if the study vaccine is safe; 3) to determine the best dose of the study vaccine 4) to learn more about the side effects of the study vaccine and how it affects the immune system; and 5) to determine if folate binding protein expression in tumor is associated with the effectiveness of the vaccine.
As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.
Principal Investigator(s)
Gauduin, Marie-Claire E.
Funded by
UTHSCSA
The goal of this project is to piece together an effective HIV vaccine using the Simian Immunodeficiency Virus and the Varicella virus.
